Shanghai Nianxing Industrial Co., Ltd
China
Product Name: GW274150 phosphate
Price:
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang

438542-15-5

438542-15-5 structure

Name: GW274150 phosphate
Chemical Name: GW274150 phosphate
CAS Number: 438542-15-5
Molecular Formula: C₈H₂₀N₃O₆PS
Molecular Weight: 317.30
Catalog: Signaling Pathways Immunology/Inflammation NO Synthase
Create Date: 2020-06-02 02:12:41
Modify Date: 2024-01-03 19:06:22
GW274150 phosphate is a potent, selective, orally active and NADPH-dependent inhibitor of human inducible nitric oxide synthase (iNOS) (IC50=2.19 μM; Kd=40 nM) and rat iNOS (ED50=1.15 μM). GW274150 phosphate displays less potency for both humans or rats endothelial NOS (eNOS) and neuronal NOS (nNOS). GW274150 phosphate exerts a protective role in an acute model of lung injury inflammation[1][2].

Name	GW274150 phosphate

Description	GW274150 phosphate is a potent, selective, orally active and NADPH-dependent inhibitor of human inducible nitric oxide synthase (iNOS) (IC50=2.19 μM; Kd=40 nM) and rat iNOS (ED50=1.15 μM). GW274150 phosphate displays less potency for both humans or rats endothelial NOS (eNOS) and neuronal NOS (nNOS). GW274150 phosphate exerts a protective role in an acute model of lung injury inflammation[1][2].
Related Catalog	Signaling Pathways >> Immunology/Inflammation >> NO Synthase Research Areas >> Inflammation/Immunology Research Areas >> Neurological Disease
Target	Kd: 40 nM (iNOS)[1] IC50: 2.19 μM (human iNOS); 544 μM (human eNOS); 177 μM (human nNOS) ED50: 1.15 μM (rat iNOS); 252 μM (rat nNOS)[1]
In Vitro	GW274150 phosphate inhibits intracellular iNOS in J774 cells in a time-dependent manner, reaching IC50 values of 0.2±0.04 μM[1]. GW274150 is >260-fold and 219-fold selective for iNOS against eNOS and nNOS in rat tissues, respectively. And it displays >100-fold and >80-fold for human iNOS against human eNOS and nNOS, respectively[1].
In Vivo	GW274150 phosphate is a long-acting (5 h half‐life in rats) iNOS inhibitor and is able to inhibit LPS‐mediated increase in plasma NO2-, NO3- levels 14 h after single intraperitoneal dose (ED50=3 mg/kg)[2]. GW274150 phosphate (intraperitoneal injection; 2.5, 5, and 10 mg/kg; before carrageenan injection) reduces the degree of lung injury induced by carrageenan in a dose-related fashion. Oedema formation and PMNs infiltration in the pleural cavity are also significantly attenuated in a dose‐related manner in rats[2]. GW274150 phosphate (oral adminstration; 30 mg/kg; twice daily; 7 days) leads to significant neuroprotection, however, it displays a bell-shaped neuroprotective profile, being ineffective at high doses in 6-OHDA rat model of Parkinson disease (PD)[3]. Animal Model: SD rat[2] Dosage: 2.5, 5 and 10 mg/kg Administration: Intraperitoneal injection 5 min before carrageenan injection Result: Exerted a protective role in an acute model of inflammation, carrageenan-induced lung injury.
References	[1]. Alderton WK, et al. GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo.Br J Pharmacol. 2005 Jun;145(3):301-12. [2]. Dugo L, et al. Effects of GW274150, a novel and selective inhibitor of iNOS activity, in acute lung inflammation. Br J Pharmacol. 2004 Mar;141(6):979-87. Epub 2004 Feb [3]. Broom L, et al. Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease.Free Radic Biol Med. 2011 Mar 1;50(5):633-40.

Molecular Formula	C₈H₂₀N₃O₆PS
Molecular Weight	317.30

438542-15-5	210354-22-6
14396-43-1	33881-88-8
32288-01-0	7635-45-2
7601-54-9	54118-66-0
7518-75-4	115120-50-8
1158522-08-7	2764014-91-5
940364-43-2	134104-43-1
131615-57-1	6906-52-1
2167714-70-5	930439-75-1
1018584-77-4	1375289-11-4